Dafna-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
83
Total Value
352661806
Accession Number
0001389933-25-000002
Form Type
13F-HR
Manager Name
Dafna-Capital-Management
Data Enrichment
94% identified
78 identified5 unidentified

Holdings

83 positions
Manager:
Search and click to pin securities to the top
Arcus Biosciences, Inc.
Shares:625.1K
Value:$4.9M
04351PAD3
Shares:
Value:$4.7M
DEXCOM INC
Shares:65.6K
Value:$4.5M
BIOCRYST PHARMACEUTICALS INC
Shares:558.3K
Value:$4.2M
Edgewise Therapeutics, Inc.
Shares:183.1K
Value:$4.0M
GALAPAGOS NV
Shares:130.2K
Value:$3.3M
Inogen Inc
Shares:458.1K
Value:$3.3M
INSULET CORP
Shares:11.9K
Value:$3.1M
Alkermes plc.
Shares:94.2K
Value:$3.1M
Kura Oncology, Inc.
Shares:463.4K
Value:$3.1M
Stoke Therapeutics, Inc.
Shares:444.0K
Value:$3.0M
Immunovant, Inc.
Shares:170.0K
Value:$2.9M
Bicara Therapeutics Inc.
Shares:212.0K
Value:$2.8M
ACCURAY INC
Shares:1.2M
Value:$2.2M
2seventy bio, Inc.
Shares:429.3K
Value:$2.1M
ProQR Therapeutics N.V.
Shares:1.6M
Value:$2.1M
COMPASS Pathways plc
Shares:711.0K
Value:$2.0M
Allogene Therapeutics, Inc.
Shares:1.4M
Value:$2.0M
TELA Bio, Inc.
Shares:1.4M
Value:$1.8M
ALIGN TECHNOLOGY INC
Shares:11.0K
Value:$1.7M